CVS Health reports $106.1 billion second-quarter revenue
Share
- The single biggest result was CVS Health reporting $106.1 billion in second-quarter revenues and an adjusted EPS of $2.58.
- The company generated $10.6 billion in year-to-date operating cash flow and raised its full-year earnings guidance.
- Management stated they expect to continue their margin recovery plan while deploying agentic AI tools across operational centers.
CVS Health (NYSE:CVS) reported second-quarter revenues of $106.1 billion, representing a 7.3% increase driven by broad segment gains.
This financial outcome presents a strong contrast to the prior year, bolstered by the absence of historical litigation charges.
"As our businesses work together to deliver a technology-powered care engagement experience, we continue to deliver strong performance," said CVS Health Chairman and CEO David Joyner.
The corporation recorded $4.7 billion in operating income, with its health care benefits segment experiencing an 85.5% adjusted income increase.
Management raised full-year forecasts, and following the announcement, CVS Health's share price was down at $104.27.
The business generated $10.6 billion in operating cash flow while the health services division achieved 11.5% revenue growth.
The pharmacy division saw a 10.2% adjusted income rise, aided by Rite Aid acquisitions and new AI deployments.
Frequently asked questions
More from United States
Amazon Q3 revenue accelerates 12% to $201.9 billion as AWS growth accelerates
Intel Q3 revenue skyrockets 21% to $16.5B as data center sales surge
Merck raises FY profit outlook as Q3 revenue climbs 5% to $18.1B
Eli Lilly Q3 revenue surges 39% to $24.4 billion as guidance rises
Enterprise Products Q3 EBITDA jumps 16% to $2.8 billion
KBR Q3 revenue rises 5% to $2 billion as adjusted EBITDA grows 12%
